Compound details
S-Allylcysteine
| Compound ID | CDAMM00808 |
|---|---|
| Common name | S-Allylcysteine | IUPAC name | 2-amino-3-prop-2-enylsulfanylpropanoic acid |
| Molecular formula | C6H11NO2S |
| Retention time | 10.06 |
|---|---|
| Adduct | [M+Na]+ |
| Actual mz | 184.04 | Theoretical mz | 184.04 |
| Error | 1.53 |
| Ionizaton mode | Positive |
| Instrument type | LC-MS/MS-QTOF, spectrum predicted by MS-DIAL v4.9 integrated with MS-FINDER 3.60 |
| Score | 7.1372 |
| Inchi key | ZFAHNWWNDFHPOH-UHFFFAOYNA-N |
|---|---|
| Smiles | O=C(O)C(N)CSCC=C |
| Superclass | Organic acids and derivatives |
| Class | Carboxylic acids and derivatives |
| Uniprot ID | Gene name | Target name | TTD_ID | Prediction source |
|---|---|---|---|---|
| P35228 | NOS2 | Nitric oxide synthase, inducible | T02703 | SEA |
| O00222 | GRM8 | Metabotropic glutamate receptor 8 | T77548 | SEA |
| Q4U2R8 | SLC22A6 | Solute carrier family 22 member 6 (by homology) | T70680 | SEA |
| P43005 | SLC1A1 | Excitatory amino acid transporter 3 | T31721 | SEA |
| P39086 | GRIK1 | Glutamate receptor ionotropic kainate 1 | T73495 | SEA |
| Q13002 | GRIK2 | Glutamate receptor ionotropic kainate 2 | T58178 | SEA |
| O15303 | GRM6 | Metabotropic glutamate receptor 6 | T55956 | SEA |
| Q16478 | GRIK5 | Glutamate receptor ionotropic kainate 5 | T87930 | SEA |
| Q13003 | GRIK3 | Glutamate receptor ionotropic kainate 3 | T68876 | SEA |
| Q16719 | KYNU | Kynureninase | T99912 | SEA |
| Q01650 | SLC7A5 | L-type amino acid transporter 1 (by homology) | T48330 | SEA |
| P52732 | KIF11 | Kinesin-like protein 1 | T28484 | SEA |
| P14384 | CPM | Carboxypeptidase M | T65483 | SEA |
| O60603 | TLR2 | Toll-like receptor 2 | T82078 | SEA |
| TTD_ID | Disease_ID | Disease name | ICD_11 | Uniprot ID | Gene names |
|---|---|---|---|---|---|
| T02703 | DI0083 | Chronic kidney disease | [ICD-11: GB61] | P35228 | NOS2 |
| T02703 | DI0320 | Osteoarthritis | [ICD-11: FA00-FA05] | P35228 | NOS2 |
| T02703 | DI0375 | Sepsis | [ICD-11: 1G40-1G41] | P35228 | NOS2 |
| T02703 | DI0391 | Solid tumour/cancer | [ICD-11: 2A00-2F9Z] | P35228 | NOS2 |
| T70680 | DI0167 | Gout | [ICD-11: FA25] | Q4U2R8 | SLC22A6 |
| T70680 | DI0206 | Inborn purine/pyrimidine/nucleotide metabolism error | [ICD-11: 5C55] | Q4U2R8 | SLC22A6 |
| T70680 | DI0310 | Ocular disease | [ICD-11: N.A.] | Q4U2R8 | SLC22A6 |
| T73495 | DI0134 | Epilepsy/seizure | [ICD-11: 8A61-8A6Z] | P39086 | GRIK1 |
| T73495 | DI0396 | Substance abuse | [ICD-11: 6C40] | P39086 | GRIK1 |
| T99912 | DI0046 | Bacterial infection | [ICD-11: 1A00-1C4Z] | Q16719 | KYNU |
| T99912 | DI0062 | Breast cancer | [ICD-11: 2C60-2C6Y] | Q16719 | KYNU |
| T28484 | DI0012 | Acute myeloid leukaemia | [ICD-11: 2A60] | P52732 | KIF11 |
| T28484 | DI0172 | Head and neck cancer | [ICD-11: 2D42] | P52732 | KIF11 |
| T28484 | DI0241 | Lymphoma | [ICD-11: 2A80-2A86] | P52732 | KIF11 |
| T28484 | DI0245 | Malignant haematopoietic neoplasm | [ICD-11: 2B33] | P52732 | KIF11 |
| T28484 | DI0274 | Multiple myeloma | [ICD-11: 2A83] | P52732 | KIF11 |
| T28484 | DI0321 | Ovarian cancer | [ICD-11: 2C73] | P52732 | KIF11 |
| T28484 | DI0361 | Renal cell carcinoma | [ICD-11: 2C90] | P52732 | KIF11 |
| T28484 | DI0391 | Solid tumour/cancer | [ICD-11: 2A00-2F9Z] | P52732 | KIF11 |
| T82078 | DI0346 | Prostate cancer | [ICD-11: 2C82] | O60603 | TLR2 |